(Q44327361)

English

DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients

scientific article published on 5 August 2013

Statements

DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit